// App-Quantinova.ai

5156 : Targeting N-myristoylation in B-cell lymphomas as a therapeutic strategy

Researchers

Presenter

  • Erwan Beauchamp

Principal Investigators

  • Megan C. Yap

  • Maneka A. Perinpanayagam

  • Jay M. Gamma

  • Krista M. Vincent

  • Raymond Lai

  • Wei-Feng Dong

  • Manikandan Lakshmanan

  • Anandhkumar Raju

  • Vinay Tergaonkar

  • Soo Yong Tan

  • Soon Thye Lim

  • Lynne Postovit

  • Kevin D. Read

  • David W. Gray

  • Paul G. Wyatt

  • John R. Mackey

  • Luc G. Berthiaume

Medical Centers

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • Institute of Molecular and Cell Biology, Singapore, Singapore

  • Advanced Molecular Pathology Lab, Proteos, Singapore

  • National Heart Centre, Singapore

  • University of Dundee, Dundee, United Kingdom

Locations

  • Canada

  • Singapore

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • cMYC

  • CREB-binding protein

Drug/Treatment

  • Ibrutinib

  • dasatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved